Sei Investments CO Mirati Therapeutics, Inc. Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $213,600 - $292,584	-5,912 Reduced 11.77%	44,302 $1.6 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $1.83 Million - $2.72 Million	50,214 New	50,214 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $52,003 - $75,775	874 Added 1.62%	54,669 $3.82 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $1.9 Million - $4.3 Million	48,496 Added 915.19%	53,795 $3.61 Million
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $3,790 - $7,548	-50 Reduced 0.93%	5,299 $436,000

Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $1,584 - $2,283	12 Added 0.22%	5,349 $785,000
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $270,734 - $363,595	-2,049 Reduced 27.74%	5,337 $944,000
Q2 2021 Aug 06, 2021	SELL	$144.0 - $179.73 $650,880 - $812,379	-4,520 Reduced 37.96%	7,386 $1.19 Million
Q1 2021 May 12, 2021	BUY	$158.92 - $221.61 $412,556 - $575,299	2,596 Added 27.88%	11,906 $2.28 Million
Q4 2020 Feb 08, 2021	SELL	$162.05 - $240.27 $885,117 - $1.31 Million	-5,462 Reduced 36.98%	9,310 $2.04 Million
Q3 2020 Nov 06, 2020	BUY	$113.26 - $167.27 $621,910 - $918,479	5,491 Added 59.16%	14,772 $2.45 Million
Q2 2020 Aug 17, 2020	BUY	$72.01 - $120.39 $181,609 - $303,623	2,522 Added 37.31%	9,281 $1.06 Million
Q2 2020 Aug 11, 2020	SELL	$72.01 - $120.39 $243,537 - $407,158	-3,382 Reduced 33.35%	6,759 $871,000
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $57,359 - $95,524	-822 Reduced 7.5%	10,141 $780,000
Q4 2019 Feb 06, 2020	BUY	$70.76 - $128.86 $283 - $515	4 Added 0.04%	10,963 $1.41 Million
Q3 2019 Nov 12, 2019	SELL	$77.91 - $109.6 $96,296 - $135,465	-1,236 Reduced 10.14%	10,959 $854,000
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $497,871 - $876,317	-8,369 Reduced 40.7%	12,195 $1.26 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $897,618 - $1.62 Million	20,564 New	20,564 $1.51 Million
Q3 2018 Nov 08, 2018	SELL	$47.1 - $62.7 $949,253 - $1.26 Million	-20,154 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$26.05 - $52.4 $525,011 - $1.06 Million	20,154 New	20,154 $994,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account